Choosing between Henry Meds and Nurx for weight loss involves evaluating specialized, cost-optimized GLP-1 access against integrated women's health platform coordination. Henry Meds launched in 2021 as a focused weight loss telehealth provider offering some of the market's most affordable semaglutide and tirzepatide access through board-certified obesity medicine specialists serving all genders. Nurx started in 2015 as a women's health platform covering birth control and reproductive services, expanding to include weight loss as one component of complete women's wellness offerings integrating metabolic, hormonal, and reproductive health management. This comparison examines treatment approaches, pricing differences, clinical expertise specialization, platform integration capabilities, insurance considerations, and patient fit to help you determine which model aligns with your weight loss goals, gender, complete health needs, and whether you prioritize cost-optimized specialized treatment or coordinated multi-service women's health management.
Platform Overview
Henry Meds launched in 2021 as a specialized weight loss telehealth platform focusing on affordable GLP-1 medication access. The company has positioned itself as one of the most cost-effective providers of semaglutide and tirzepatide, serving patients across the United States through board-certified healthcare providers. Henry Meds operates with transparent pricing, straightforward telemedicine consultations, and emphasis on medication affordability without sacrificing medical supervision quality. The platform has grown rapidly by addressing the significant cost barrier preventing many patients from accessing breakthrough obesity medications, maintaining HIPAA-compliant operations serving all 50 states, according to
FDA semaglutide safety information, according to
GoodRx medication pricing data.
Nurx launched in 2015 as a women's health telehealth platform initially focused on birth control and reproductive health services, expanding over time to include weight loss, hair loss, and mental health treatments. The platform serves women's health needs completely through licensed healthcare providers in multiple states. Nurx expanded into weight loss in response to demand for GLP-1 medications, adding semaglutide and tirzepatide to its service offerings. The platform operates as a multi-category women's health provider integrating weight loss with its core reproductive health, dermatology, and wellness services.
Weight Loss Treatment Approach
Henry Meds GLP-1 Specialization: Henry Meds exclusively focuses on weight loss through GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The platform provides both branded and compounded formulations depending on availability and patient preference, following evidence-based dosing protocols from the
American Association of Clinical Endocrinology. Henry Meds offers medical consultations through board-certified physicians specializing in obesity medicine, with ongoing prescription management, dose adjustments, and side effect monitoring. The platform's exclusive focus on weight loss enables deep specialization in GLP-1 therapy optimization.
Nurx Integrated Women's Health Model: Nurx offers weight loss medications as part of a broader women's health platform that includes birth control, emergency contraception, HPV screening, acne treatment, anti-aging skincare, migraine management, genital herpes treatment, and mental health services. The weight loss component provides semaglutide and tirzepatide through licensed healthcare providers, integrated with Nurx complete women's wellness approach. This integrated model allows coordination between weight loss treatment and other aspects of women's health, potentially addressing interconnected concerns like hormonal influences on weight, PCOS-related obesity, or metabolic issues affecting reproductive health.
Clinical Evidence: Both platforms provide access to medications with well-established weight loss efficacy. FDA Wegovy prescribing information demonstrates semaglutide 2.4mg produces average weight loss of 12.4% body weight over 68 weeks.
FDA Zepbound label shows tirzepatide achieving 15-20.9% weight loss depending on dose. The medications deliver equivalent results when properly dosed, though Henry Meds specialized focus on obesity treatment may provide advantages in optimizing GLP-1 therapy compared to Nurx broader but potentially less specialized approach to weight management.
Pricing and Affordability Comparison
Henry Meds Budget-Friendly Pricing: Henry Meds has established itself as one of the most affordable GLP-1 providers, with monthly costs ranging from $197-297/month for compounded semaglutide and tirzepatide. The platform charges a $49 one-time consultation fee for physician evaluation. Henry Meds operates primarily as a cash-pay service with transparent pricing, though the platform accepts some insurance for consultation fees and is expanding insurance coverage for medications. HSA/FSA payment options are available. Annual costs for uninsured patients typically range from $2,364-3,564, positioning Henry Meds among the lowest-cost legitimate medical providers of GLP-1 medications.
Nurx Women's Health Pricing Model: Nurx weight loss pricing ranges from $249-349/month for GLP-1 medications depending on formulation and dose. The platform charges consultation fees that vary by service, with initial evaluations typically costing $15-30 for most services (weight loss consultation fees may differ). Nurx accepts insurance for many services and works to maximize insurance coverage where available, though weight loss medications often require cash payment. The platform offers HSA/FSA payment options. Annual costs for cash-pay weight loss treatment range from $2,988-4,188, representing moderately higher costs than specialized GLP-1 providers like Henry Meds but including potential benefits from integrated women's health platform.
Cost-Value Assessment: Henry Meds offers substantial cost advantages with monthly savings of approximately $52-52/month ($624-624 annually) compared to Nurx for equivalent GLP-1 medications. For patients primarily motivated by cost optimization in accessing weight loss medications, Henry Meds represents superior value. However, Nurx higher costs include integration with complete women's health services, potential coordination with birth control, hormonal treatments, or other wellness needs, and established insurance billing infrastructure for many non-weight-loss services.
Obesity journal research on treatment value suggests that while medication access is crucial, complete health management addressing interconnected issues can improve outcomes—an area where Nurx integrated women's health model may provide advantages for patients with multiple concurrent health needs despite higher weight loss medication costs.
Medical Team and Clinical Expertise
Henry Meds Obesity Medicine Focus: Henry Meds operates with board-certified physicians and healthcare providers specializing in obesity medicine and metabolic disease management. The platform's exclusive focus on weight loss enables providers to develop deep expertise in GLP-1 therapy, including advanced knowledge of dose optimization, side effect management strategies, medication selection between semaglutide and tirzepatide, and patient-specific treatment customization. Providers follow clinical guidelines from the
Obesity Medicine Association and stay current with rapidly evolving GLP-1 research. Henry Meds offers asynchronous telemedicine consultations with typical response times under 48 hours for clinical questions, providing ongoing medication management throughout treatment.
Nurx Multi-Specialty Women's Health Providers: Nurx employs licensed healthcare providers including physicians and nurse practitioners covering women's health specialties—reproductive health, dermatology, primary care, and now weight management. While providers are licensed and qualified, Nurx generalist women's health model means individual providers may have less specialized expertise specifically in obesity medicine compared to platforms exclusively focused on weight loss. The breadth of services requires provider knowledge across multiple domains, potentially limiting deep specialization in any single area including GLP-1 optimization. Nurx provides asynchronous consultations through its platform with response times varying by service complexity.
Clinical Expertise Comparison: Henry Meds specialized focus on obesity treatment enables concentrated provider expertise in GLP-1 therapy optimization, complex side effect management, and weight loss medication selection—expertise directly applicable to every patient interaction. Nurx broader women's health model offers complete care coordination but may lack the depth of obesity medicine specialization found in focused platforms. JAMA research on specialist vs generalist care suggests that for complex chronic conditions like obesity, specialist management often produces superior outcomes. For straightforward GLP-1 prescriptions, both platforms provide adequate medical supervision; for complex cases requiring expert obesity medicine management, Henry Meds specialized clinical focus represents an advantage.
Platform Features and Service Integration
Henry Meds Focused Platform: Henry Meds provides a streamlined telehealth platform optimized specifically for weight loss medication management. The service includes asynchronous messaging with providers, prescription management, medication tracking, refill coordination, and educational resources about GLP-1 medications. Henry Meds has invested in making the weight loss treatment process efficient and affordable while maintaining appropriate medical supervision. The platform offers mobile-responsive web interface but focuses on essential functionality rather than extensive digital health features, prioritizing cost efficiency and weight loss specialization.
Nurx Complete Women's Health Platform: Nurx operates a sophisticated multi-service platform integrating weight loss with birth control management, STI testing and treatment, dermatology services, migraine management, herpes treatment, mental health support, and wellness products. The platform provides mobile apps for iOS and Android, secure messaging with healthcare providers across services, prescription management for multiple medication types, home testing kit coordination, and educational content spanning women's health topics. Nurx technology enables patients to manage diverse health needs through unified account with consolidated medical history, potentially improving care coordination for interconnected conditions.
Integration Benefits and Trade-offs: For patients needing only weight loss medication, Henry Meds focused platform provides exactly what's needed at optimal cost without additional complexity. For women with multiple health needs—particularly those where hormonal factors, metabolic health, and reproductive concerns intersect—Nurx integrated platform enables complete management of interconnected issues through one provider network.
ACOG guidance on women's health integration emphasizes the value of coordinated care for conditions like PCOS-related obesity, hormonal weight gain, or metabolic issues affecting reproductive health. Nurx ability to address these interconnected concerns through one platform provides meaningful convenience and potentially better health outcomes for women with complex health profiles, though at higher cost than specialized weight loss platforms.
Insurance and Payment Options
Henry Meds Cash-Pay Focus: Henry Meds operates primarily as a cash-pay service with transparent, affordable pricing designed to be accessible for uninsured patients or those whose insurance does not cover GLP-1 medications for weight loss. The platform accepts HSA/FSA payments, allowing patients with health savings accounts to use pre-tax dollars for treatment. Henry Meds is expanding insurance acceptance and works with some plans for consultation fees, but the core value proposition centers on affordable cash pricing that often beats insurance copays or matches costs after high deductibles. The cash-pay model enables consistent, predictable pricing nationwide, according to
FDA semaglutide safety information, according to
GoodRx medication pricing data, according to
Kaiser Family Foundation coverage analysis.
Nurx Insurance Billing Infrastructure: Nurx has established complete insurance billing capabilities, accepting many major insurance plans for consultations and medications where coverage exists. The platform actively works to maximize insurance benefits for patients, handling prior authorizations, insurance verification, and claims processing. For services like birth control, STI testing, and some other treatments, Nurx can often secure full or partial insurance coverage. However, weight loss medications frequently require cash payment even through insured platforms due to limited coverage. Nurx insurance infrastructure provides value for patients whose plans cover certain services, though GLP-1 medications specifically often remain cash-pay regardless of insurance status.
Payment Model Implications: For patients specifically seeking weight loss treatment without insurance coverage for GLP-1 medications (the majority scenario), Henry Meds optimized cash-pay pricing ($197-297/month) provides superior value compared to Nurx cash pricing ($249-349/month). For patients with good insurance coverage who use or plan to use multiple Nurx services beyond weight loss—such as birth control, STI screening, or dermatology treatments—Nurx insurance billing capabilities can deliver overall value across services even if weight loss medications specifically remain cash-pay. The optimal choice depends on whether weight loss is isolated need (favoring Henry Meds) or part of broader insured women's health management (potentially favoring Nurx despite higher weight loss costs).
Target Patient and Use Case Fit
Henry Meds Ideal Patient Profile: Henry Meds serves patients of any gender seeking the most affordable legitimate access to GLP-1 weight loss medications with specialized obesity medicine expertise. The platform excels for patients who prioritize cost optimization, want focused weight loss treatment without additional services, value deep clinical expertise in GLP-1 therapy, and need straightforward, efficient medication access. Henry Meds fits patients seeking a single-purpose solution for obesity treatment, those without insurance coverage for weight loss medications, and individuals who want specialized rather than generalist medical management of their weight loss journey.
Nurx Women's Health Integration Profile: Nurx serves women seeking integrated health management across weight loss and other wellness needs including reproductive health, dermatology, mental health, or chronic condition management. The platform provides optimal value for women who benefit from coordinated care addressing hormonal influences on weight (PCOS, perimenopause, birth control side effects), need multiple concurrent health services manageable through one provider network, value complete women's health expertise beyond weight loss alone, or have insurance coverage making Nurx multi-service integration cost-effective. Nurx fits women viewing weight loss as one component of broader health optimization requiring coordinated, complete care.
Gender and Service Scope Considerations: Henry Meds serves all genders with specialized weight loss focus, while Nurx primarily serves women through women's health lens (though some services may be available to other patients). For men seeking weight loss treatment, Henry Meds represents the clear choice. For women, the decision depends on whether isolated, cost-optimized weight loss treatment (Henry Meds) or integrated women's health management including weight loss as one component (Nurx) better fits individual health needs and priorities.
North American Menopause Society research demonstrates that women's weight management often involves complex hormonal, reproductive, and metabolic factors that may benefit from integrated rather than isolated treatment approaches—a consideration favoring Nurx model for women with hormonal or gynecological factors influencing weight.
How We Tested Nurx vs Henry Meds
Our Comparison Methodology
This comparison is based on complete analysis of treatment approaches, pricing structures, clinical expertise, platform capabilities, service integration models, and patient fit considerations from both Henry Meds and Nurx, supplemented by peer-reviewed research on obesity treatment, women's health integration, and telehealth service models.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication labels including Wegovy (semaglutide) and Zepbound (tirzepatide), clinical guidelines from the American Association of Clinical Endocrinology, and treatment standards from the Obesity Medicine Association. Information on medication efficacy, dosing protocols, and clinical management reflects established medical evidence for GLP-1 therapies.
Research Foundation: Analysis incorporates peer-reviewed research from Obesity journal on treatment value and clinical support, JAMA research on specialist versus generalist care quality, ACOG guidance on integrated women's health care, and North American Menopause Society research on hormonal factors in women's weight management. These sources inform assessment of specialized versus integrated care models, clinical expertise importance, and coordinated women's health treatment benefits.
Pricing Analysis: Pricing information verified through direct platform review as of January 2026, including consultation fees, monthly medication costs, insurance acceptance policies, and payment options. Cost comparisons calculated for typical treatment courses providing accurate annual expense estimates for cash-pay patients.
Service Verification: Platform capabilities, medical team credentials, service integration models, medication formularies, and target patient populations evaluated through platform documentation, provider licensing verification, service scope assessment, and specialty focus analysis. Evaluation includes clinical expertise depth, multi-service coordination capabilities, and patient fit considerations.
Independence: This comparison receives no compensation from either platform and aims to provide evidence-based analysis helping patients choose appropriate weight loss telehealth services based on clinical needs, cost considerations, gender-specific requirements, and whether specialized weight loss focus or integrated women's health management better serves individual health goals.
Final Verdict: Nurx vs Henry Meds
Choose Henry Meds if: You seek the most affordable legitimate access to GLP-1 weight loss medications with specialized obesity medicine expertise, with monthly costs of $197-297 representing substantial savings compared to alternatives. You value deep clinical specialization in GLP-1 therapy optimization, side effect management, and medication selection from providers focused exclusively on weight loss. You need only weight loss treatment without additional health services, and prefer focused, efficient medication access over multi-service platform integration. You are male (Henry Meds serves all genders while Nurx focuses on women's health). You are uninsured or your insurance does not cover weight loss medications, making cash-pay cost optimization your priority. You want straightforward, specialized obesity treatment without need for coordinated women's health management.
Choose Nurx if: You are a woman with multiple health needs benefiting from integrated care coordination across weight loss, reproductive health, dermatology, mental health, or chronic condition management through one platform. You have hormonal factors influencing weight (PCOS, perimenopause, birth control effects) that may benefit from coordinated women's health expertise addressing metabolic-reproductive interconnections. You currently use or plan to use Nurx for other services (birth control, STI screening, acne treatment) where insurance coverage or service integration provides value beyond isolated weight loss treatment. You prefer complete women's health platform managing diverse needs through unified provider network and consolidated medical history. You value integrated care coordination over cost optimization for weight loss specifically, accepting higher medication costs ($249-349/month) in exchange for complete women's wellness platform.
Bottom line: Henry Meds and Nurx represent fundamentally different service models—Henry Meds offers specialized, cost-optimized GLP-1 access ($197-297/month) with deep obesity medicine expertise serving all genders through focused weight loss platform, while Nurx integrates weight loss ($249-349/month) into complete women's health services coordinating reproductive, hormonal, metabolic, and wellness needs through unified platform. For cost-conscious patients seeking specialized weight loss treatment, particularly men or women without additional health service needs, Henry Meds provides superior value through lower costs ($624-624 annual savings), specialized clinical expertise, and efficient focused service delivery. For women with multiple health concerns, particularly those involving hormonal influences on weight or metabolic-reproductive interconnections, Nurx integrated model enables complete coordinated care addressing complex health profiles through one provider network despite higher weight loss costs—the coordination benefits and complete women's health expertise may justify premium pricing for patients with multifaceted health needs. The decision depends on whether specialized cost-effective weight loss treatment (Henry Meds) or integrated complete women's health management including weight loss as one component (Nurx) better aligns with your gender, health complexity, service needs, and whether you prioritize cost optimization or care coordination in your obesity treatment approach.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
